机构地区:[1]首都医科大学附属北京妇产医院/北京妇幼保健院生殖医学科,北京100026
出 处:《中华预防医学杂志》2022年第7期973-979,共7页Chinese Journal of Preventive Medicine
基 金:北京市科学技术委员会首都临床特色应用研究项目(Z171100001017047)。
摘 要:为探讨黄体酮转化子宫内膜日的血清雌二醇浓度能否预测激素替代周期冻融胚胎移植的妊娠结局。本文采用病例对照研究,回顾性分析首都医科大学附属北京妇产医院生殖医学科于2018年1月至2020年12月进行的激素替代疗法冻融胚胎移植(hormone replacement therapy-frozen thawed embryo transfer,HRT-FET)共230个周期,血清雌二醇浓度在139.5~3 941.0 pg/ml之间。根据子宫内膜转化日血清雌二醇浓度的百分位数将患者分为3组:对照组(<第25百分位数,n=58例),高雌二醇组(第25~75百分位数,n=112例)和超高雌二醇组(>第75百分位数,n=60例)。比较3组的基本特征及妊娠结局,主要观察指标是活产率,次要观察指标是临床妊娠率。数据分析采用F检验和Kruskal-Wallis(H)检验进行计量资料组间比较,采用χ2检验进行计数资料组间比较。结果显示,一般情况:3组取卵周期时的年龄、抗苗勒管激素(anti-Müllerian hormone,AMH)、基础窦卵泡数(antral follicle count,AFC)、体重指数(body mass index,BMI)、不孕年限、原发不孕占比等方面的差异无统计学意义(F=2.375,H=5.479,H=5.374,F=1.391,H=4.779,χ2=1.969,P>0.05)。FET周期治疗情况:3组子宫内膜转化前的孕酮(P)浓度、转化日子宫内膜厚度、单胚胎移植占比、囊胚移植占比之间的差异无统计学意义(H=5.359,H=5.957,χ2=0.626,χ2=4.532,P>0.05);3组在FET周期中子宫内膜转化前的雌激素用药天数,高雌二醇组为13.0(12.0,14.0)d、超高雌二醇组为13.0(12.0,15.0)d,均比对照组13.0(12.0,13.3)d的时间长,差异有统计学意义(H=8.897,P<0.05);高雌二醇组在内膜转化前的E2浓度为1 560.4(1 170.2,1 848.2)pg/ml、超高雌二醇组E2浓度为2 420.9(2 131.0,2 849.2)pg/ml,明显高于对照组的E2浓度238.8(206.9,287.0)pg/ml,差异有统计学意义(H=194.84,P<0.05)。3组的妊娠结局:3组的临床妊娠率,对照组37.9%、高雌二醇组51.8%、超高雌二醇组40.0%,其中高雌二醇组临床妊娠率�To analyze whether the serum concentration of estradiol on the day of progesterone conversion could predict the pregnancy outcome of frozen-thawed embryo transfer in hormone replacement cycle.In this paper,a case-control study was conducted to retrospectively analyze the 230 cycles of hormone replacement therapy-frozen thawed embryo transfer(HRT-FET)conducted by the Department of Reproductive Medicine,Beijing Obstetrics and Gynecology Hospital,Capital Medical University from January 2018 to December 2020.The concentration of serum estradiol was between 139.5-3941.0 pg/ml.According to the percentile of serum estradiol concentration on the day of endometrial transformation,patients were divided into three groups:control group(<25th percentile,n=58),high estradiol group(25th-75th percentile,n=112)and ultra-high estradiol group(>75th percentile,n=60).Comparing the basic characteristics and pregnancy outcome of the three groups,the main observation index was the live birth rate,and the secondary observation index was the clinical pregnancy rate.F test and Kruskal-Wallis(H)test were used to compare the measurement data,andχ2 test was used to compare the counting data.The results showed that there was no significant difference in age,anti-Müllerian hormone(AMH),antral follicle count(AFC),body mass index(BMI),years of infertility and the proportion of primary infertility among the three groups(F=2.375,H=5.479,H=5.374,F=1.391,H=4.779,χ²=1.969,P>0.05).FET cycle treatment:There was no significant difference in the concentration of progesterone(P)before transformation,the thickness of endometrium on the day of transformation,the proportion of single embryo transfer and blastocyst transfer among the three groups(H=5.359,H=5.957,χ²=0.626,χ²=4.532,P>0.05).The days of estrogen administration before endometrial transformation in the three groups during the FET cycle were 13.0(12.0,14.0)days in the high estradiol group and 13.0(12.0,15.0)days in the ultra-high estradiol group,which were significantly longer than those in t
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...